Elucidating genetic mechanisms involved in Attention-Deficit/ Hyperactivity Disorder (ADHD) has been challenging. Relatively unexplored is the fact that genetic mechanisms can differ with age. The current study explored the association between dopaminergic and serotonergic genes, ADHD symptoms, and neurocognitive functioning in relation to age. Associations of three genetic ADHD risk factors, DAT1, DRD4, and 5-HTT with symptoms and six neurocognitive measures were explored in two samples of the NeuroIMAGE study: 756 children, adolescents, and young adults with ADHD, their siblings, and controls (M age 17 years, SD 3.2), and 393 parents with and without ADHD (M age 48 years, SD 4.8). Association analyses were performed in both samples, and effects were compared to address dichotomous age effects. Gene*age interactions were examined to address continuous age effects. Moderating effects of age were found for DRD4-7R carriership and ADHD symptoms in the adult group only; in the adolescents the 5-HTT LL genotype was differentially associated with inhibition and with motor timing at different ages, and to inhibition in adults; DAT1 10-6 haplotype carriership showed differential working memory performance depending on age. None of our effects survived correction for multiple comparisons. Our results are preliminary, but may point to differential genotype-phenotype associations at different ages. This can be seen as a proof of concept for the importance of age in dopaminergic and serotonergic genetic association analyses. Our findings are consistent with the idea that genetic and neurocognitive mechanisms underlying ADHD may change throughout life. Ó 2015 Wiley Periodicals, Inc.
471Neuropsychiatric Genetics
INTRODUCTIONAttention Deficit/Hyperactivity Disorder (ADHD) is a highly prevalent neurodevelopmental disorder characterized by symptoms of inattention and/or hyperactivity and impulsivity [Diagnostic and Statistical Manual of Mental Disorders, DSM-5, 2013;Polanczyk et al., 2007]. ADHD often persists into adulthood [Turgay et al., 2012] and is substantially influenced by genetic factors [Thapar et al., 2013]. The heritability of ADHD is estimated to be $76% , but gene-finding in ADHD has been difficult. This is likely due to phenotypic and genetic heterogeneity in combination with very small effect sizes of common genetic variants contributing to ADHD risk [Gizer et al., 2009] and/or genetic risk factors of stronger effects being rare and non-specific [Poelmans et al., 2011;Thapar et al., 2013]. Associations with ADHD have been studied most extensively for candidate genes in the dopaminergic, serotonergic, and noradrenergic systems, all hypothesized to play a role in ADHD [Gizer et al., 2009;Banaschewski et al., 2010]. Dopaminergic genes are considered key candidates for ADHD because of the strong therapeutic effects of stimulant medication [Volkow et al., 2002;Faraone and Buitelaar, 2010; Del Campo et al., 2011]. A central role of serotonergic genes is suggested by the effects on (early) brain development [Azmitia,...